Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3M Skin and Nasal Antiseptic is a preoperative antiseptic solution containing povidone-iodine 5% w/w (0.5% available iodine) designed for application to the skin and nasal mucosa prior to surgery. Its primary mechanism of action is the rapid, broad-spectrum antimicrobial activity of povidone-iodine, which disrupts microbial proteins and oxidizes cell components, leading to cell death. The product is formulated with a pH-balanced buffered system and film-forming polymer for increased persistence on skin or mucosa. It reduces bacterial load—including Staphylococcus aureus—by up to 99.9% within minutes of application, with effects lasting at least six hours on the skin and up to twelve hours in the nares[2][3][5]. It is used as part of infection prevention protocols in surgical settings to reduce surgical site infections (SSIs), especially those caused by endogenous nasal flora[2][6]. Developed by 3M Health Care (now Solventum), it supports antibiotic stewardship by providing an effective non-antibiotic decolonization option that has not been shown to induce resistance[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3M Skin and Nasal Antiseptic.